Global Gepants Drugs Market Research Report 2024(Status and Outlook)
Report Overview
Gepants drugs are a class of medications primarily used for the treatment of migraine headaches. These drugs work by blocking the activity of calcitonin gene-related peptide (CGRP), a neuropeptide involved in the transmission of pain signals. Gepants are known for their specificity in targeting CGRP receptors, offering a novel approach to migraine treatment with potentially fewer side effects compared to traditional medications.
The current market size for gepants drugs in 2023 is estimated at approximately USD 400 million. This market is expected to grow at a compound annual growth rate (CAGR) of 15.75% from 2024 to 2032, reaching a value of USD 1.2 billion by the end of the forecast period. The key growth drivers for the gepants market include the increasing prevalence of migraines globally, growing awareness and diagnosis rates, as well as the demand for more effective and tolerable treatment options.
One of the prominent trends in the gepants market is the shift towards personalized medicine and precision healthcare. With advancements in genetic testing and biomarker identification, healthcare providers can better tailor treatment plans for individual patients, including the use of gepants based on their specific genetic profiles or migraine characteristics. This trend not only enhances treatment efficacy but also contributes to patient satisfaction and outcomes.
Another significant trend is the expanding research and development efforts in the field of migraine therapeutics, particularly focusing on novel formulations and delivery methods for gepants. For instance, the development of long-acting gepants or alternative administration routes such as nasal sprays or patches aims to improve patient compliance and convenience, thereby driving market growth. Additionally, collaborations between pharmaceutical companies and research institutions are fostering innovation in gepants drug development, leading to a pipeline of promising candidates.
Regional market distribution shows that North America currently dominates the gepants market, attributed to factors such as high migraine prevalence, well-established healthcare infrastructure, and early adoption of novel therapies. Europe follows closely behind, driven by increasing healthcare expenditure and a growing emphasis on patient-centric care. Asia-Pacific is poised for significant growth due to a large underserved patient population, improving access to healthcare, and rising awareness about migraine management.
Despite the optimistic market outlook, the gepants market faces challenges such as pricing pressures, regulatory hurdles, and competition from existing migraine treatments. For instance, the high cost of gepants drugs may limit access for some patients, especially in regions with limited insurance coverage or affordability issues. Moreover, the need for extensive clinical trials and regulatory approvals poses challenges in bringing new gepants to market quickly, delaying potential benefits for patients.
In conclusion, the gepants market presents substantial growth opportunities driven by increasing migraine prevalence, advancements in personalized medicine, and ongoing research and development initiatives. To capitalize on these opportunities, stakeholders in the market should focus on addressing pricing concerns, accelerating regulatory processes, and fostering innovation in gepants drug development to meet the evolving needs of patients worldwide.
This report provides a deep insight into the global Gepants Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gepants Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gepants Drugs market in any manner.
Global Gepants Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
PFIZER INC
ABBVIE INC
Market Segmentation (by Type)
Rimegepant
Atogepant
Zavegepant
Ubrogepant
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gepants Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Gepants drugs are a class of medications primarily used for the treatment of migraine headaches. These drugs work by blocking the activity of calcitonin gene-related peptide (CGRP), a neuropeptide involved in the transmission of pain signals. Gepants are known for their specificity in targeting CGRP receptors, offering a novel approach to migraine treatment with potentially fewer side effects compared to traditional medications.
The current market size for gepants drugs in 2023 is estimated at approximately USD 400 million. This market is expected to grow at a compound annual growth rate (CAGR) of 15.75% from 2024 to 2032, reaching a value of USD 1.2 billion by the end of the forecast period. The key growth drivers for the gepants market include the increasing prevalence of migraines globally, growing awareness and diagnosis rates, as well as the demand for more effective and tolerable treatment options.
One of the prominent trends in the gepants market is the shift towards personalized medicine and precision healthcare. With advancements in genetic testing and biomarker identification, healthcare providers can better tailor treatment plans for individual patients, including the use of gepants based on their specific genetic profiles or migraine characteristics. This trend not only enhances treatment efficacy but also contributes to patient satisfaction and outcomes.
Another significant trend is the expanding research and development efforts in the field of migraine therapeutics, particularly focusing on novel formulations and delivery methods for gepants. For instance, the development of long-acting gepants or alternative administration routes such as nasal sprays or patches aims to improve patient compliance and convenience, thereby driving market growth. Additionally, collaborations between pharmaceutical companies and research institutions are fostering innovation in gepants drug development, leading to a pipeline of promising candidates.
Regional market distribution shows that North America currently dominates the gepants market, attributed to factors such as high migraine prevalence, well-established healthcare infrastructure, and early adoption of novel therapies. Europe follows closely behind, driven by increasing healthcare expenditure and a growing emphasis on patient-centric care. Asia-Pacific is poised for significant growth due to a large underserved patient population, improving access to healthcare, and rising awareness about migraine management.
Despite the optimistic market outlook, the gepants market faces challenges such as pricing pressures, regulatory hurdles, and competition from existing migraine treatments. For instance, the high cost of gepants drugs may limit access for some patients, especially in regions with limited insurance coverage or affordability issues. Moreover, the need for extensive clinical trials and regulatory approvals poses challenges in bringing new gepants to market quickly, delaying potential benefits for patients.
In conclusion, the gepants market presents substantial growth opportunities driven by increasing migraine prevalence, advancements in personalized medicine, and ongoing research and development initiatives. To capitalize on these opportunities, stakeholders in the market should focus on addressing pricing concerns, accelerating regulatory processes, and fostering innovation in gepants drug development to meet the evolving needs of patients worldwide.
This report provides a deep insight into the global Gepants Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gepants Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gepants Drugs market in any manner.
Global Gepants Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
PFIZER INC
ABBVIE INC
Market Segmentation (by Type)
Rimegepant
Atogepant
Zavegepant
Ubrogepant
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gepants Drugs Market
- Overview of the regional outlook of the Gepants Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gepants Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gepants Drugs
1.2 Key Market Segments
1.2.1 Gepants Drugs Segment by Type
1.2.2 Gepants Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GEPANTS DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gepants Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Gepants Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
2.4 Macroeconomic Analysis
3 GEPANTS DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Gepants Drugs Sales by Manufacturers (2019-2024)
3.2 Global Gepants Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Gepants Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gepants Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gepants Drugs Sales Sites, Area Served, Product Type
3.6 Gepants Drugs Market Competitive Situation and Trends
3.6.1 Gepants Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gepants Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GEPANTS DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Gepants Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GEPANTS DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GEPANTS DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gepants Drugs Sales Market Share by Type (2019-2024)
6.3 Global Gepants Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Gepants Drugs Price by Type (2019-2024)
7 GEPANTS DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gepants Drugs Market Sales by Application (2019-2024)
7.3 Global Gepants Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Gepants Drugs Sales Growth Rate by Application (2019-2024)
8 GEPANTS DRUGS MARKET SALES BY REGION
8.1 Global Gepants Drugs Sales by Region
8.1.1 Global Gepants Drugs Sales by Region
8.1.2 Global Gepants Drugs Sales Market Share by Region
8.2 Global Gepants Drugs Market Size by Region
8.2.1 Global Gepants Drugs Market Size by Region
8.2.2 Global Gepants Drugs Market Size Market Share by Region
8.3 North America
8.3.1 North America Gepants Drugs Sales by Country
8.3.2 North America Gepants Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gepants Drugs Sales by Country
8.4.2 Europe Gepants Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Russia Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gepants Drugs Sales by Region
8.5.2 China
8.5.3 Japan
8.5.4 South Korea
8.5.5 India
8.5.6 Southeast Asia
8.6 Asia Pacific
8.6.1 Asia Pacific Gepants Drugs Market Size by Region
8.6.2 Asia Pacific Gepants Drugs Market Size by Region
8.6.3 China
8.6.4 Japan
8.6.5 South Korea
8.6.6 India
8.6.7 Southeast Asia
8.7 South America
8.7.1 South America Gepants Drugs Sales by Country
8.7.2 South America Gepants Drugs Market Size by Country
8.7.3 Brazil
8.7.4 Argentina
8.7.5 Columbia
8.8 Middle East and Africa
8.8.1 Middle East and Africa Gepants Drugs Sales by Region
8.8.2 Middle East and Africa Gepants Drugs Market Size by Region
8.8.3 Saudi Arabia
8.8.4 UAE
8.8.5 Egypt
8.8.6 Nigeria
8.8.7 South Africa
9 GEPANTS DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Gepants Drugs by Region (2019-2024)
9.2 Global Gepants Drugs Revenue Market Share by Region (2019-2024)
9.3 Global Gepants Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Gepants Drugs Production
9.4.1 North America Gepants Drugs Production Growth Rate (2019-2024)
9.4.2 North America Gepants Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Gepants Drugs Production
9.5.1 Europe Gepants Drugs Production Growth Rate (2019-2024)
9.5.2 Europe Gepants Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Gepants Drugs Production (2019-2024)
9.6.1 Japan Gepants Drugs Production Growth Rate (2019-2024)
9.6.2 Japan Gepants Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Gepants Drugs Production (2019-2024)
9.7.1 China Gepants Drugs Production Growth Rate (2019-2024)
9.7.2 China Gepants Drugs Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 PFIZER INC
10.1.1 PFIZER INC Gepants Drugs Basic Information
10.1.2 PFIZER INC Gepants Drugs Product Overview
10.1.3 PFIZER INC Gepants Drugs Product Market Performance
10.1.4 PFIZER INC Business Overview
10.1.5 PFIZER INC Gepants Drugs SWOT Analysis
10.1.6 PFIZER INC Recent Developments
10.2 ABBVIE INC
10.2.1 ABBVIE INC Gepants Drugs Basic Information
10.2.2 ABBVIE INC Gepants Drugs Product Overview
10.2.3 ABBVIE INC Gepants Drugs Product Market Performance
10.2.4 ABBVIE INC Business Overview
10.2.5 ABBVIE INC Gepants Drugs SWOT Analysis
10.2.6 ABBVIE INC Recent Developments
11 GEPANTS DRUGS MARKET FORECAST BY REGION
11.1 Global Gepants Drugs Market Size Forecast
11.2 Global Gepants Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gepants Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Gepants Drugs Market Size Forecast by Region
11.2.4 South America Gepants Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gepants Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Gepants Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Gepants Drugs by Type (2025-2032)
12.1.2 Global Gepants Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Gepants Drugs by Type (2025-2032)
12.2 Global Gepants Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Gepants Drugs Sales (K MT) Forecast by Application
12.2.2 Global Gepants Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gepants Drugs
1.2 Key Market Segments
1.2.1 Gepants Drugs Segment by Type
1.2.2 Gepants Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GEPANTS DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gepants Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Gepants Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
2.4 Macroeconomic Analysis
3 GEPANTS DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Gepants Drugs Sales by Manufacturers (2019-2024)
3.2 Global Gepants Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Gepants Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gepants Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gepants Drugs Sales Sites, Area Served, Product Type
3.6 Gepants Drugs Market Competitive Situation and Trends
3.6.1 Gepants Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gepants Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GEPANTS DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Gepants Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GEPANTS DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GEPANTS DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gepants Drugs Sales Market Share by Type (2019-2024)
6.3 Global Gepants Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Gepants Drugs Price by Type (2019-2024)
7 GEPANTS DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gepants Drugs Market Sales by Application (2019-2024)
7.3 Global Gepants Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Gepants Drugs Sales Growth Rate by Application (2019-2024)
8 GEPANTS DRUGS MARKET SALES BY REGION
8.1 Global Gepants Drugs Sales by Region
8.1.1 Global Gepants Drugs Sales by Region
8.1.2 Global Gepants Drugs Sales Market Share by Region
8.2 Global Gepants Drugs Market Size by Region
8.2.1 Global Gepants Drugs Market Size by Region
8.2.2 Global Gepants Drugs Market Size Market Share by Region
8.3 North America
8.3.1 North America Gepants Drugs Sales by Country
8.3.2 North America Gepants Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gepants Drugs Sales by Country
8.4.2 Europe Gepants Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Russia Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gepants Drugs Sales by Region
8.5.2 China
8.5.3 Japan
8.5.4 South Korea
8.5.5 India
8.5.6 Southeast Asia
8.6 Asia Pacific
8.6.1 Asia Pacific Gepants Drugs Market Size by Region
8.6.2 Asia Pacific Gepants Drugs Market Size by Region
8.6.3 China
8.6.4 Japan
8.6.5 South Korea
8.6.6 India
8.6.7 Southeast Asia
8.7 South America
8.7.1 South America Gepants Drugs Sales by Country
8.7.2 South America Gepants Drugs Market Size by Country
8.7.3 Brazil
8.7.4 Argentina
8.7.5 Columbia
8.8 Middle East and Africa
8.8.1 Middle East and Africa Gepants Drugs Sales by Region
8.8.2 Middle East and Africa Gepants Drugs Market Size by Region
8.8.3 Saudi Arabia
8.8.4 UAE
8.8.5 Egypt
8.8.6 Nigeria
8.8.7 South Africa
9 GEPANTS DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Gepants Drugs by Region (2019-2024)
9.2 Global Gepants Drugs Revenue Market Share by Region (2019-2024)
9.3 Global Gepants Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Gepants Drugs Production
9.4.1 North America Gepants Drugs Production Growth Rate (2019-2024)
9.4.2 North America Gepants Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Gepants Drugs Production
9.5.1 Europe Gepants Drugs Production Growth Rate (2019-2024)
9.5.2 Europe Gepants Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Gepants Drugs Production (2019-2024)
9.6.1 Japan Gepants Drugs Production Growth Rate (2019-2024)
9.6.2 Japan Gepants Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Gepants Drugs Production (2019-2024)
9.7.1 China Gepants Drugs Production Growth Rate (2019-2024)
9.7.2 China Gepants Drugs Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 PFIZER INC
10.1.1 PFIZER INC Gepants Drugs Basic Information
10.1.2 PFIZER INC Gepants Drugs Product Overview
10.1.3 PFIZER INC Gepants Drugs Product Market Performance
10.1.4 PFIZER INC Business Overview
10.1.5 PFIZER INC Gepants Drugs SWOT Analysis
10.1.6 PFIZER INC Recent Developments
10.2 ABBVIE INC
10.2.1 ABBVIE INC Gepants Drugs Basic Information
10.2.2 ABBVIE INC Gepants Drugs Product Overview
10.2.3 ABBVIE INC Gepants Drugs Product Market Performance
10.2.4 ABBVIE INC Business Overview
10.2.5 ABBVIE INC Gepants Drugs SWOT Analysis
10.2.6 ABBVIE INC Recent Developments
11 GEPANTS DRUGS MARKET FORECAST BY REGION
11.1 Global Gepants Drugs Market Size Forecast
11.2 Global Gepants Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gepants Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Gepants Drugs Market Size Forecast by Region
11.2.4 South America Gepants Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gepants Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Gepants Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Gepants Drugs by Type (2025-2032)
12.1.2 Global Gepants Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Gepants Drugs by Type (2025-2032)
12.2 Global Gepants Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Gepants Drugs Sales (K MT) Forecast by Application
12.2.2 Global Gepants Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
